Orion Corporation will publish its Financial Statement Release 2013 on Tuesday, 4 February 2014.
The publication dates of the Interim Reports in 2014 are as follows:
Interim Report January-March 2014 Tuesday, 29 April 2014
Interim Report January-June 2014 Tuesday, 29 July 2014
Interim Report January-September 2014 Tuesday, 21 October 2014
The Financial Statements and the report of the Board of Directors 2013 will be published on the company's website latest on week 10/2014.
The Annual General Meeting is planned to be held on Tuesday, 25 March 2014 in Helsinki.
Orion's financial reports and related presentation material are available on the Group's website at http://www.orion.fi/investors promptly after the publishing. The website also provides a possibility to register on Orion's mailing lists for releases.
| Timo Lappalainen |
President and CEO
| Jari Karlson |
Orionintie 1A, FI-02200 Espoo, Finland
Orion is a globally operating Finnish company developing pharmaceuticals and diagnostic tests - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company is continuously developing new drugs and treatment methods. Pharmaceutical R&D focuses on central nervous system drugs, oncology and critical care drugs, and Easyhaler® pulmonary drugs.
Orion's net sales in 2012 amounted to EUR 980 million and the company had about 3,500 employees. Orion's A and B shares are listed on NASDAQ OMX Helsinki.